D-Wave Quantum stock slides 5% as share-resale filing hangs over QBTS trade

D-Wave Quantum Inc shares slipped 5.4% to $25.94 early Friday afternoon, wiping out an initial jump. The stock opened at $27.14 and fell to a low of $25.71, with more than 23 million shares traded.

New York, January 23, 2026, 13:07 EST — Regular session

D-Wave Quantum Inc shares slipped 5.4% to $25.94 early Friday afternoon, wiping out an initial jump. The stock opened at $27.14 and fell to a low of $25.71, with more than 23 million shares traded.

The drop matters because QBTS has become a magnet for rapid trades: any hint of increased supply or changes to its product strategy triggers swift moves in the stock. The company is under pressure to move beyond lab talk and deliver steady commercial results.

On Jan. 20, a prospectus supplement was filed registering the resale of up to 10,430,444 shares by certain selling stockholders, mostly tied to D-Wave’s Quantum Circuits acquisition. The document made clear that D-Wave itself will receive no proceeds from these sales. It also noted that the selling stockholders “may sell any, all or none” of the shares. Among the venture investors named as eligible resellers are Sequoia Capital funds, ARCH Venture funds, and Canaan. SEC

D-Wave confirmed earlier this week it has closed the acquisition of Quantum Circuits, adding “error-corrected” gate-model tech to its lineup alongside its annealing systems. CEO Alan Baratz described the deal as “a watershed moment” in a company release. Rob Schoelkopf, Quantum Circuits co-founder, said the merger gives D-Wave “a decisive advantage” in gate-model quantum computing. D-Wave Quantum

In a nutshell, quantum annealing is D-Wave’s specialized technique targeting certain optimization problems, while gate-model machines cover a wider range of quantum computing tasks and are the go-to for many rivals. D-Wave pitches itself as a “dual-platform” company, letting clients tap into its machines via the cloud.

Registering shares for resale doesn’t mean they’ll hit the market right away. Still, it establishes a clear potential supply number. Traders tend to price in this overhang quickly, especially if the stock already sees big daily moves.

The selling pressure persisted. IonQ slid 2.4%, Rigetti eased 2.7%, and Quantum Computing Inc fell 2.9%. By comparison, the wider market barely budged: the SPDR S&P 500 ETF dipped marginally, while the Invesco QQQ ETF inched higher.

Investors are tuning out today’s headlines, zeroing in instead on what’s ahead: will major shareholders offload shares on any rally, and can the company keep up its pace with new product launches rather than getting stuck in red tape?

The risk is obvious. If selling shareholders hurry to dump shares during the registration period, the market could be swamped with supply. This is especially risky in a sector where sentiment flips quickly and valuations frequently outrun real cash flow.

Execution presents a fresh challenge. D-Wave is launching a new hardware initiative while promising progress on a second computing architecture, yet quantum development schedules are known for delays.

D-Wave’s Qubits 2026 user conference will take place Jan. 27-28 in Boca Raton, Florida. The company is expected to reveal its newest roadmap and showcase customer projects during the event.

For now, expect the stock to react chiefly to sector momentum, signs of secondary selling, and fresh details on the post-deal product strategy.

Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech. His coverage ranges from stocks and technology to economic developments across global markets. He worked in investment research and market analysis before becoming a financial journalist and is a graduate of the Lahore University of Management Sciences (LUMS).

Why Wells Fargo stock is down today: WFC slips after $100 million mortgage-aid settlement notice
Previous Story

Why Wells Fargo stock is down today: WFC slips after $100 million mortgage-aid settlement notice

ImmunityBio stock tumbles after glioblastoma update; what to watch before Monday
Next Story

ImmunityBio stock tumbles after glioblastoma update; what to watch before Monday